Antibodies to Human Immunodeficiency Virus (HTLV-III/LAV) in People from Lagos and Cross River States of Nigeria
Authors:
- I. AkinseteIAI. Akinsete
- E.E. WilliamsEWE.E. Williams
- J. SchneiderJSJ. Schneider
- I. WendlerIWI. Wendler
- G. HunsmannGHG. Hunsmann
- 1 January 1988
- journal article
- research article
- Published by S. Karger AG in Acta Haematologica
- Vol. 79 (2) , 91-93
Abstract
Using enzyme-linked immunosorbent assay (ELISA) and confirmatory immunoprecipitation tests, sera from 640 Nigerians from Lagos and Cross River States were examined for antibodies against HIV. These comprised 570 blood donors and their family members, 56 patients with various haematological conditions and 14 patients with acute Plasmodium falciparum infection. None of the sera was positive for HTLV-III/ LAV antibodies by immunoprecipitation, although 12 (1.9%) sera were positive by ELISA.Keywords
This publication has 9 references indexed in Scilit:
- New Human T-Lymphotropic Retrovirus Related to Simian T-Lymphotropic Virus Type III (STLV-III AGM )Science, 1986
- AIDS Virus Infection in Nairobi ProstitutesNew England Journal of Medicine, 1986
- ELISA HTLV RETROVIRUS ANTIBODY REACTIVITY ASSOCIATED WITH MALARIA AND IMMUNE COMPLEXES IN HEALTHY AFRICANSThe Lancet, 1985
- HTLV-III SEROLOGY DISTINGUISHES ATYPICAL AND ENDEMIC KAPOSI'S SARCOMA IN AFRICAThe Lancet, 1985
- PREVALENCE OF ANTIBODY TO HUMAN T-LYMPHOTROPIC VIRUS TYPE III IN AIDS AND AIDS-RISK PATIENTS IN BRITAINThe Lancet, 1984
- Detection, Isolation, and Continuous Production of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and Pre-AIDSScience, 1984
- Acquired Immunodeficiency Syndrome in African PatientsNew England Journal of Medicine, 1984
- Acquired Immunodeficiency Syndrome: Epidemiologic, Clinical, Immunologic, and Therapeutic ConsiderationsAnnals of Internal Medicine, 1984
- Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)Science, 1983